MedPath

To assess the efficacy of Avastin injection in treatment of pterygium

Phase 3
Conditions
pterygium.
PTERYGIUM
Registration Number
IRCT2014092819319N1
Lead Sponsor
Vice chancellor for research, Iran University of Medical Science
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
40
Inclusion Criteria

Patients with 20 to 70 years old, with primary bilateral fleshy pterygium invading between 1 to 4 mm into the cornea.

Exclusion criteria: Any evidence of cancer or other ocular diseases except refraction errors (including anterior segment and posterior segment), diabetic patients and pregnancy.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath